These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14970853)

  • 1. Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.
    Murphy PS; Viviers L; Abson C; Rowland IJ; Brada M; Leach MO; Dzik-Jurasz AS
    Br J Cancer; 2004 Feb; 90(4):781-6. PubMed ID: 14970853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
    Guillevin R; Menuel C; Taillibert S; Capelle L; Costalat R; Abud L; Habas C; De Marco G; Hoang-Xuan K; Chiras J; Vallée JN
    Br J Cancer; 2011 Jun; 104(12):1854-61. PubMed ID: 21610707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy.
    Sijens PE; Heesters MA; Enting RH; van der Graaf WT; Potze JH; Irwan R; Meiners LC; Oudkerk M
    Cancer Invest; 2007 Dec; 25(8):706-10. PubMed ID: 18058466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy.
    Charnley N; West CM; Barnett CM; Brock C; Bydder GM; Glaser M; Newlands ES; Swindell R; Matthews J; Price P
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):331-8. PubMed ID: 16839701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temozolomide: a novel oral alkylating agent.
    Danson SJ; Middleton MR
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):13-9. PubMed ID: 12113120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.
    Brada M; Judson I; Beale P; Moore S; Reidenberg P; Statkevich P; Dugan M; Batra V; Cutler D
    Br J Cancer; 1999 Nov; 81(6):1022-30. PubMed ID: 10576660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.
    Lashford LS; Thiesse P; Jouvet A; Jaspan T; Couanet D; Griffiths PD; Doz F; Ironside J; Robson K; Hobson R; Dugan M; Pearson AD; Vassal G; Frappaz D;
    J Clin Oncol; 2002 Dec; 20(24):4684-91. PubMed ID: 12488414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temozolomide in the treatment of recurrent malignant glioma.
    Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
    Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of temozolomide using an extended continuous oral schedule.
    Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
    Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide in children with progressive low-grade glioma.
    Gururangan S; Fisher MJ; Allen JC; Herndon JE; Quinn JA; Reardon DA; Vredenburgh JJ; Desjardins A; Phillips PC; Watral MA; Krauser JM; Friedman AH; Friedman HS
    Neuro Oncol; 2007 Apr; 9(2):161-8. PubMed ID: 17347491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early metabolic responses in temozolomide treated low-grade glioma patients.
    Wyss M; Hofer S; Bruehlmeier M; Hefti M; Uhlmann C; Bärtschi E; Buettner UW; Roelcke U
    J Neurooncol; 2009 Oct; 95(1):87-93. PubMed ID: 19381442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
    Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
    Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.
    Harris MT; Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2001 Jul; 8(4):325-7. PubMed ID: 11437571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas.
    Motomura K; Natsume A; Wakabayashi T
    J Neurooncol; 2012 Jan; 106(1):209-11. PubMed ID: 21725854
    [No Abstract]   [Full Text] [Related]  

  • 15. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
    Lodi R; Setola E; Tonon C; Ambrosetto P; Franceschi E; Crinò L; Barbiroli B; Cortelli P
    Magn Reson Imaging; 2003 Nov; 21(9):1003-7. PubMed ID: 14684203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma.
    Korones DN; Benita-Weiss M; Coyle TE; Mechtler L; Bushunow P; Evans B; Reardon DA; Quinn JA; Friedman H
    Cancer; 2003 Apr; 97(8):1963-8. PubMed ID: 12673724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temozolomide in the treatment of recurrent malignant glioma in Chinese patients.
    Chan DT; Poon WS; Chan YL; Ng HK
    Hong Kong Med J; 2005 Dec; 11(6):452-6. PubMed ID: 16340021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Favourable result for temozolomide in recurrent high-grade glioma].
    Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic history of low-grade gliomas before and after temozolomide treatment.
    Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY
    Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma.
    Hau P; Koch D; Hundsberger T; Marg E; Bauer B; Rudolph R; Rauch M; Brenner A; Rieckmann P; Schuth J; Jauch T; Koch H; Bogdahn U
    Neurology; 2007 Feb; 68(9):688-90. PubMed ID: 17325277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.